, Caractéristiques des études et données démographiques

, Lorsque cet index était réduit de plus de moitié ceci traduisait une efficacité de la décompression chirurgicale. D'autres critères d'évaluation ont été observés tels que la Visual Analogic Scale (échelle visuelle analogique), la satisfaction des patients, ou l'amélioration des symptômes ressentie entre l, Les 34 études incluses regroupaient 3033 interventions réalisées sur 3006 patients

, Parmi les 34 études incluses, 5 sont des études randomisées et contrôlées (ERC) dont une versus placebo

E. A. Macgregor, J. D. Rosenberg, and T. Kurth, Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study, Cephalalgia. 1 juill, vol.51, issue.6, p.1545602, 2011.

D. C. Buse, E. W. Loder, J. A. Gorman, W. F. Stewart, M. L. Reed et al., Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study, Headache. sept, vol.53, issue.8, p.127899, 2013.

R. B. Lipton, M. E. Bigal, M. Diamond, F. Freitag, M. L. Reed et al., Migraine prevalence, disease burden, and the need for preventive therapy, Neurology. 30 janv, vol.68, issue.5, p.3439, 2007.

E. Estemalik and S. Tepper, Preventive treatment in migraine and the new US guidelines, Neuropsychiatr Dis Treat, vol.9, p.70920, 2013.

J. L. Natoli, A. Manack, B. Dean, Q. Butler, C. C. Turkel et al., Global prevalence of chronic migraine: a systematic review, Cephalalgia Int J Headache. mai, vol.30, issue.5, p.599609, 2010.

R. C. Burch, S. Loder, E. Loder, and T. A. Smitherman, The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies, Headache. janv, vol.55, issue.1, p.2134, 2015.

L. J. Stovner, J. Zwart, K. Hagen, G. M. Terwindt, and J. Pascual, Epidemiology of headache in Europe, Eur J Neurol. 1 avr, vol.13, issue.4, p.33345, 2006.

D. Lawrence and M. D. Goldberg, New Approaches for the Management and Treatment of Migraine 2 Suppl), Am J Manag Care, vol.15, issue.2005, 2005.

T. J. Steiner, K. Paemeleire, R. Jensen, D. Valade, L. Savi et al., European principles of management of common headache disorders in primary care, J Headache Pain, vol.8, issue.1, pp.3-47, 2007.

E. Van-leeuwen, K. Paemeleire, P. Van-royen, M. Goossens, and K. Dirven,

R. De-bonne-pratique, Prise en charge de la migraine au cabinet du médecin généraliste, Rev Médecine Générale, 2011.

S. D. Silberstein, S. Holland, F. Freitag, D. W. Dodick, C. Argoff et al.,

, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society, Neurology. 24 avr, vol.78, issue.17, p.133745, 2012.

R. B. Lipton and S. D. Silberstein, Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention, Headache. mars, vol.55, issue.2, pp.103-122, 2015.

. Anaes, Prise en charge diagnostique et thérapeutique de la migraine chez l'adulte et chez l'enfant: aspects cliniques et économiques, 2002.

E. Loder, R. Burch, and P. Rizzoli, The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines, Headache. juin, vol.52, issue.6, p.93045, 2012.

S. D. Silberstein, Preventive Migraine Treatment, Contin Lifelong Learn Neurol. août, vol.21, p.97389, 2004.

S. Diamond and J. L. Medina, Double blind study of propranolol for migraine prophylaxis, Headache. mars, vol.16, issue.1, p.247, 1976.

B. Mikkelsen, K. K. Pedersen, and L. V. Christiansen, Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo, Acta Neurol Scand. avr, vol.73, issue.4, p.4237, 1986.

K. A. Holroyd, C. K. Cottrell, O. Donnell, F. J. Cordingley, G. E. Drew et al., Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial, BMJ. 29 sept, vol.341, p.4871, 2010.

H. C. Diener, M. Föh, C. Iaccarino, P. Wessely, H. Isler et al., Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group, Cephalalgia Int J Headache, vol.16, issue.6, p.4417, 1996.

A. Pradalier, G. Serratrice, M. Collard, E. Hirsch, J. Feve et al., Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study, Cephalalgia Int J Headache. déc, vol.9, issue.4, p.24753, 1989.

P. Kangasniemi, A. R. Andersen, P. G. Andersson, N. E. Gilhus, C. Hedman et al., Classic migraine: effective prophylaxis with metoprolol, Cephalalgia Int J Headache. déc, vol.7, issue.4, p.2318, 1987.

P. G. Andersson, S. Dahl, J. H. Hansen, P. E. Hansen, C. Hedman et al.,

, Prophylactic Treatment of Classical and Non-Classical Migraine With Metoprolol-a Comparison with Placebo, Cephalalgia. 1 déc, vol.3, issue.4, p.20712, 1983.

B. Standnes, The Prophylactic Effect of Timolol Versus Propranolol and Placebo in Common Migraine: Beta-Blockers in Migraine: Cephalalgia, 2016.

S. Disponible-sur-;-stellar, S. P. Ahrens, A. R. Meibohm, and S. A. Reines, Migraine Prevention With Timolol: A Double-blind Crossover Study, JAMA, vol.252, issue.18, p.257680, 1984.

P. Tfelthansen, B. Standnes, P. Kangasneimi, H. Hakkarainen, and J. Olesen, Timolol vs propranolol vs placebo in common migraine prophylaxis: a doubleblind multicenter trial, Acta Neurol Scand. 1 janv, vol.69, issue.1, p.18, 1984.

T. A. Shamliyan, J. Choi, R. Ramakrishnan, J. B. Miller, S. Wang et al.,

, Preventive Pharmacologic Treatments for Episodic Migraine in Adults, J Gen Intern Med. sept, vol.28, issue.9, p.1225, 2013.

R. N. Gray, R. E. Goslin, D. C. Mccrory, K. Eberlein, J. Tulsky et al., Drug Treatments for the Prevention of Migraine Headache

M. Linde, W. M. Mulleners, E. P. Chronicle, and D. C. Mccrory, Topiramate for the prophylaxis of episodic migraine in adults, Cochrane Database Syst Rev. 24 juin, issue.6, p.10610, 1999.

A. V. Margulis, A. A. Mitchell, S. M. Gilboa, M. M. Werler, M. A. Mittleman et al., Use of topiramate in pregnancy and risk of oral clefts, Am J Obstet Gynecol, vol.207, issue.5, pp.405-406, 2012.

N. T. Mathew, J. R. Saper, S. D. Silberstein, L. Rankin, H. G. Markley et al., Migraine prophylaxis with divalproex, Arch Neurol. mars, vol.52, issue.3, p.2816, 1995.

M. J. Morrell, Reproductive and metabolic disorders in women with epilepsy, Epilepsia, vol.44, 2003.

S. D. Silberstein, R. B. Lipton, D. W. Dodick, F. G. Freitag, N. Ramadan et al., Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial, Headache. févr, vol.47, issue.2, p.17080, 2007.

H. Diener, G. Bussone, J. C. Van-oene, M. Lahaye, S. Schwalen et al.,

, Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebocontrolled study, Cephalalgia Int J Headache. juill, vol.27, issue.7, p.81423, 2007.

H. Diener, D. W. Dodick, P. J. Goadsby, R. B. Lipton, J. Olesen et al., Chronic migraine-classification, characteristics and treatment, Nat Rev Neurol. mars, vol.8, issue.3, p.16271, 2012.

A. Messali, J. C. Sanderson, A. M. Blumenfeld, P. J. Goadsby, D. C. Buse et al., Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A WebBased Survey, Headache. févr, vol.56, issue.2, p.30622, 2016.

J. Munakata, E. Hazard, D. Serrano, D. Klingman, M. Rupnow et al.,

, Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study, Headache J Head Face Pain. 1 avr, vol.49, issue.4, p.498508, 2009.

L. M. Bloudek, M. Stokes, D. C. Buse, T. K. Wilcox, R. B. Lipton et al., Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS), J Headache Pain. 1 juill, vol.13, issue.5, p.36178, 2012.

B. Guyuron, J. S. Kriegler, J. Davis, and S. B. Amini, Comprehensive Surgical Treatment of Migraine Headaches, Plast Reconstr Surg. janv, vol.115, issue.1, p.1, 2005.

M. T. Liu, H. Chim, and B. Guyuron, Outcome Comparison of Endoscopic and Transpalpebral Decompression for Treatment of Frontal Migraine Headaches, Plast Reconstr Surg. mai, vol.129, issue.5, p.1113, 2012.

A. Totonchi, N. Pashmini, and B. Guyuron, The Zygomaticotemporal Branch of the Trigeminal Nerve: An Anatomical Study, Plast Reconstr Surg. janv, vol.115, issue.1, p.273, 2005.

D. E. Kurlander, A. Punjabi, M. T. Liu, A. Sattar, and B. Guyuron, In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (Site II), Plast Reconstr Surg. avr, vol.133, issue.4, p.897903, 2014.

B. Guyuron, D. Harvey, and D. Reed, A Prospective Randomized Outcomes Comparison of Two Temple Migraine Trigger Site Deactivation Techniques, Plast Reconstr Surg. juill, vol.136, issue.1, p.159, 2015.

J. E. Janis, D. A. Hatef, I. Ducic, E. M. Reece, A. H. Hamawy et al., The Anatomy of the Greater Occipital Nerve: Part II. Compression Point Topography, Plast Reconstr Surg, vol.126, issue.5, p.1563, 2010.

L. Chmielewski, M. T. Liu, and B. Guyuron, The Role of Occipital Artery Resection in the Surgical Treatment of Occipital Migraine Headaches, Plast Reconstr Surg. mars, vol.131, issue.3, p.351, 2013.

I. Ducic, J. M. Felder, and S. A. Fantus, A systematic review of peripheral nerve interventional treatments for chronic headaches, Ann Plast Surg. avr, vol.72, issue.4, p.43945, 2014.

D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and . Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Int J Surg Lond Engl, vol.8, issue.5, p.33641, 2010.

. Home--clinicaltrials, , p.17, 2017.

, Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

J. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, Measuring inconsistency in metaanalyses, BMJ. 6 sept, vol.327, issue.7414, p.55760, 2003.

H. Diener, D. Dodick, A. S. Turkel, C. Degryse, R. Lipton et al.,

, OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial, Cephalalgia. 17 mars, vol.30, issue.7, p.80414, 2010.

A. H. Vo, R. Satori, B. Jabbari, J. Green, W. Killgore et al., Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial, Aviat Space Environ Med. mai, vol.78, issue.5, pp.113-118, 2007.

G. Sandrini, A. Perrotta, C. Tassorelli, P. Torelli, F. Brighina et al., Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study, J Headache Pain. août, vol.12, issue.4, p.42733, 2011.

G. P. Jacobson, N. M. Ramadan, S. K. Aggarwal, and C. W. Newman, The Henry Ford Hospital Headache Disability Inventory (HDI), Neurology. mai, vol.44, issue.5, p.83742, 1994.

A. T. Beck, R. A. Steer, R. Ball, and W. Ranieri, Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients, J Pers Assess. déc, vol.67, issue.3, p.58897, 1996.

M. E. Bigal, A. M. Rapoport, R. B. Lipton, S. J. Tepper, and F. D. Sheftell, Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine, Headache. avr, vol.43, issue.4, p.33642, 2003.

D. D'amico, P. Mosconi, S. Genco, S. Usai, A. M. Prudenzano et al., The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version, Cephalalgia Int J Headache. déc, vol.21, issue.10, p.94752, 2001.

J. B. Bjorner, M. Kosinski, and J. E. Ware, Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales, Qual Life Res Int J Qual Life Asp Treat Care Rehabil. déc, vol.12, issue.8, p.9811002, 2003.

E. A. Schulman, A. E. Lake, P. J. Goadsby, B. L. Peterlin, S. E. Siegel et al.,

, Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society, Headache. juin, vol.48, issue.6, p.77882, 2008.

S. Silberstein, N. Mathew, J. Saper, and S. Jenkins, Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group, Headache. juin, vol.40, issue.6, p.44550, 2000.

N. Barrientos and P. Chana, Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study, J Headache Pain. déc, vol.4, issue.3, p.14651, 2003.

S. Evers, J. Vollmer-haase, S. Schwaag, A. Rahmann, I. Husstedt et al.,

, Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study, Cephalalgia Int J Headache. oct, vol.24, issue.10, p.83843, 2004.

A. H. Elkind, P. O'carroll, A. Blumenfeld, R. Degryse, and R. Dimitrova,

S. Group, A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis, J Pain Off J Am Pain Soc. oct, vol.7, issue.10, p.68896, 2006.

S. K. Aurora, M. Gawel, J. L. Brandes, S. Pokta, and A. M. Vandenburgh, Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study, Headache. avr, vol.47, issue.4, p.48699, 2007.

R. Cady and C. Schreiber, Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues, Headache. juin, vol.48, issue.6, p.90013, 2008.

M. Relja, A. C. Poole, J. Schoenen, J. Pascual, X. Lei et al., A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches, Cephalalgia Int J Headache. juin, vol.27, issue.6, p.492503, 2007.

J. R. Saper, N. T. Mathew, E. W. Loder, R. Degryse, and A. M. Vandenburgh, BoNTA-009 Study Group. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine, Pain Med Malden Mass. sept, vol.8, issue.6, p.47885, 2007.

F. G. Freitag, S. Diamond, M. Diamond, and G. Urban, Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse, Headache. févr, vol.48, issue.2, p.2019, 2008.

S. Petri, T. Tölle, A. Straube, V. Pfaffenrath, U. Stefenelli et al.,

, Botulinum toxin as preventive treatment for migraine: a randomized double-blind study, Eur Neurol, vol.62, issue.4, p.20411, 2009.

S. Aurora, D. Dodick, C. Turkel, R. Degryse, S. Silberstein et al., OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial, Cephalalgia. 17 mars, vol.30, issue.7, p.793803, 2010.

S. Chankrachang, A. Arayawichanont, N. Poungvarin, and S. Nidhinandana,

P. and T. S. , Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura, Headache. janv, vol.51, issue.1, p.5263, 2011.

L. Hollanda, L. Monteiro, and A. Melo, Botulinum toxin type a for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial. Neurol Int, vol.6, p.5133, 2014.

M. Hou, J. Xie, X. Kong, Y. Zhang, Y. Shao et al., Acupoint injection of onabotulinumtoxin A for migraines, Toxins. nov, vol.7, issue.11, p.444254, 2015.

B. Guyuron, A. Varghai, B. J. Michelow, T. Thomas, and J. Davis, Corrugator supercilii muscle resection and migraine headaches, Plast Reconstr Surg. août, vol.106, issue.2, pp.429-434, 2000.

B. Guyuron, T. Tucker, and J. Davis, Surgical treatment of migraine headaches, Plast Reconstr Surg. juin, vol.109, issue.7, p.21839, 2002.

F. Dirnberger and K. Becker, Surgical treatment of migraine headaches by corrugator muscle resection, Plast Reconstr Surg. 1 sept, vol.114, issue.3, pp.652-657, 2004.

F. Behin, B. Behin, M. E. Bigal, and R. B. Lipton, Surgical treatment of patients with refractory migraine headaches and intranasal contact points, Cephalalgia Int J Headache. juin, vol.25, issue.6, p.43943, 2005.

W. H. Bearden and R. L. Anderson, Corrugator superciliaris muscle excision for tension and migraine headaches, Ophthal Plast Reconstr Surg, vol.21, issue.6, p.41822, 2005.

F. Behin, B. Behin, D. Behin, and S. Baredes, Surgical Management of Contact Point Headaches, Headache J Head Face Pain. 1 mars, vol.45, issue.3, p.20410, 2005.

J. T. Poggi, B. E. Grizzell, and S. D. Helmer, Confirmation of surgical decompression to relieve migraine headaches, Plast Reconstr Surg. juill, vol.122, issue.1, pp.115-122, 2008.

B. Guyuron, D. Reed, J. S. Kriegler, J. Davis, N. Pashmini et al., A Placebo-Controlled Surgical Trial of the Treatment of Migraine Headaches, Plast Reconstr Surg. août, vol.124, issue.2, p.461, 2009.

A. Mohebbi, F. Memari, and S. Mohebbi, Endonasal endoscopic management of contact point headache and diagnostic criteria, Headache. févr, vol.50, issue.2, p.2428, 2010.

J. E. Janis, A. Dhanik, and J. H. Howard, Validation of the peripheral trigger point theory of migraine headaches: single-surgeon experience using botulinum toxin and surgical decompression, Plast Reconstr Surg. juill, vol.128, issue.1, p.12331, 2011.

B. Guyuron, J. S. Kriegler, J. Davis, and S. B. Amini, Five-year outcome of surgical treatment of migraine headaches, Plast Reconstr Surg. févr, vol.127, issue.2, p.6038, 2011.

J. A. De-ru, P. Schellekens, and P. Lohuis, Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients, J Neural Transm, vol.118, issue.11, p.15714, 1996.

K. Larson, M. Lee, J. Davis, and B. Guyuron, Factors contributing to migraine headache surgery failure and success, Plast Reconstr Surg, vol.128, issue.5, p.106975, 2011.

K. J. Chepla, E. Oh, B. Guyuron, M. T. Liu, H. Chim et al., Outcome Comparison of Endoscopic and Transpalpebral Decompression for Treatment of Frontal Migraine Headaches, Plast Reconstr Surg. avr, vol.129, issue.4, p.1113, 2012.

M. T. Liu, B. S. Armijo, and B. Guyuron, A Comparison of Outcome of Surgical Treatment of Migraine Headaches Using a Constellation of Symptoms versus Botulinum Toxin Type A to Identify the Trigger Sites, Plast Reconstr Surg. févr, vol.129, issue.2, p.413, 2012.

L. Chmielewski, M. T. Liu, and B. Guyuron, The Role of Occipital Artery Resection in the Surgical Treatment of Occipital Migraine Headaches, Plast Reconstr Surg. mars, vol.131, issue.3, p.351, 2013.

M. Lee, M. A. Monson, M. T. Liu, D. Reed, and B. Guyuron, Positive Botulinum Toxin Type A Response Is a Prognosticator for Migraine Surgery Success, Plast Reconstr Surg. avr, vol.131, issue.4, p.751, 2013.

M. Lee, K. Lineberry, D. Reed, and B. Guyuron, The role of the third occipital nerve in surgical treatment of occipital migraine headaches, J Plast Reconstr Aesthet Surg, vol.66, issue.10, p.13359, 2013.

I. Ducic, J. M. Felder, N. Khan, and S. Youn, Greater occipital nerve excision for occipital neuralgia refractory to nerve decompression, Ann Plast Surg. févr, vol.72, issue.2, p.1847, 2014.

D. E. Kurlander, A. Punjabi, M. T. Liu, A. Sattar, and B. Guyuron, In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (Site II), Plast Reconstr Surg. avr, vol.133, issue.4, p.897903, 2014.

L. Gfrerer, D. Y. Maman, O. Tessler, and W. Austen, Nonendoscopic Deactivation of Nerve Triggers in Migraine Headache Patients: Surgical Technique and Outcomes, Plast Reconstr Surg, vol.134, issue.4, p.771, 2014.

R. Edoardo and C. Giorgia, Frontal endoscopic myotomies for chronic headache, J Craniofac Surg. mai, vol.26, issue.3, pp.201-203, 2015.

M. Omranifard, H. Abdali, M. R. Ardakani, and M. Talebianfar, A comparison of outcome of medical and surgical treatment of migraine headache: In 1 year follow-up, Adv Biomed Res, vol.5, p.121, 2016.

Z. M. Peled, A Novel Surgical Approach to Chronic Temporal Headaches, Plast Reconstr Surg. mai, vol.137, issue.5, p.1597, 2016.

D. E. Kurlander, M. Ascha, A. Sattar, and B. Guyuron, In-Depth Review of Symptoms, Triggers, and Surgical Deactivation of Frontal Migraine Headaches (Site I), Plast Reconstr Surg. sept, vol.138, issue.3, p.6818, 2016.

M. Ascha, D. E. Kurlander, A. Sattar, J. Gatherwright, and B. Guyuron, In-Depth Review of Symptoms, Triggers, and Treatment of Occipital Migraine Headaches (Site IV), Plast Reconstr Surg. juin, vol.139, issue.6, pp.1333-1342, 2017.

J. E. Janis, J. C. Barker, and M. Palettas, Targeted Peripheral Nerve-directed Onabotulinumtoxin A Injection for Effective Long-term Therapy for Migraine Headache, Plast Reconstr Surg Glob Open. mars, vol.5, issue.3, p.1270, 2017.

L. Gfrerer, J. Lans, H. R. Faulkner, S. Nota, A. Bot et al., Ability to Cope with Pain Puts Migraine Surgery Patients in Perspective, Plast Reconstr Surg, vol.141, issue.1, p.16974, 2018.

L. Gfrerer, J. H. Hulsen, M. D. Mcleod, E. J. Wright, and W. G. Austen, Migraine Surgery: An All or Nothing Phenomenon? Prospective Evaluation of Surgical Outcomes, Ann Surg. 1 févr, 2018.

J. R. Gatherwright, Y. Wu-fienberg, and B. Guyuron, The importance of surgical maneuvers during treatment of frontal migraines (site I): A prospective, randomized cohort study evaluating foraminotomy/fasciotomy, myectomy, and arterectomy, J Plast Reconstr Aesthetic Surg JPRAS. avr, vol.71, issue.4, p.47883, 2018.

A. Jose, S. A. Nagori, and A. Roychoudhury, Surgical Management of Migraine Headache, J Craniofac Surg. mars, vol.29, issue.2, p.1068, 2018.

D. E. Kurlander, M. Ascha, A. Sattar, and B. Guyuron, In-Depth Review of Symptoms, Triggers, and Surgical Deactivation of Frontal Migraine Headaches (Site I), Plast Reconstr Surg. sept, vol.138, issue.3, p.6818, 2016.

M. T. Liu, B. S. Armijo, and B. Guyuron, A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type A to identify the trigger sites, Plast Reconstr Surg. févr, vol.129, issue.2, p.4139, 2012.

J. L. Jackson, A. Kuriyama, and Y. Hayashino, Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis, JAMA. 25 avr, vol.307, issue.16, p.173645, 2012.

A. J. Shuhendler, S. Lee, M. Siu, S. Ondovcik, K. Lam et al., Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials, Pharmacotherapy. juill, vol.29, issue.7, p.78491, 2009.

N. T. Mathew, J. Kailasam, and L. Meadors, Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily Headache, Headache J Head Face Pain. 1 févr, vol.48, issue.2, p.194200, 2008.

A. E. Hawlik, R. W. Freudenmann, E. H. Pinkhardt, C. J. Schönfeldt-lecuona, and M. Gahr,

, Fortschr Neurol Psychiatr. févr, vol.82, issue.2, p.939, 2014.

G. P. Boudreau, B. M. Grosberg, P. J. Mcallister, R. B. Lipton, and D. C. Buse, Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An openlabel, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety, Int J Gen Med, vol.8, p.7986, 2015.

K. Maasumi, N. R. Thompson, J. S. Kriegler, and S. J. Tepper, Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine. Headache, vol.55, p.121824, 2015.

M. Naumann and J. Jankovic, Safety of botulinum toxin type A: a systematic review and meta-analysis, Curr Med Res Opin. 1 juill, vol.20, issue.7, p.98190, 2004.

S. D. Silberstein, The Use of Botulinum Toxin in the Management of Headache Disorders, Semin Neurol. févr, vol.36, issue.1, p.928, 2016.

D. D'amico, A. Solari, S. Usai, P. Santoro, P. Bernardoni et al., Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study, Cephalalgia Int J Headache. juin, vol.26, issue.6, p.6916, 2006.

M. Khalil, H. W. Zafar, V. Quarshie, and F. Ahmed, Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, J Headache Pain, vol.15, p.54, 2014.

M. Ruggeri, The cost effectiveness of Botox in Italian patients with chronic migraine, Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. mai, vol.35, issue.1, p.457, 2014.

M. Naumann, Y. So, C. E. Argoff, M. K. Childers, D. D. Dykstra et al., Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology. 6 mai, vol.70, p.170714, 2008.

J. R. Couch, Placebo effect and clinical trials in migraine therapy, Neuroepidemiology, vol.6, issue.4, p.17885, 1987.

F. Benedetti, H. S. Mayberg, T. D. Wager, C. S. Stohler, and J. Zubieta, Neurobiological Mechanisms of the Placebo Effect, J Neurosci, vol.25, issue.45, p.10390402, 2005.

J. G. Speciali, M. Peres, and M. E. Bigal, Migraine treatment and placebo effect, Expert Rev Neurother. 1 mars, vol.10, issue.3, p.4139, 2010.

S. Solomon, OnabotulinumtoxinA for Treatment of Chronic Migraine: The Unblinding Problem, Headache J Head Face Pain. 1 mai, vol.53, issue.5, p.8246, 2013.

N. T. Mathew, B. M. Frishberg, M. Gawel, R. Dimitrova, J. Gibson et al., Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial, Headache. avr, vol.45, issue.4, p.293307, 2005.

S. D. Silberstein, S. R. Stark, S. M. Lucas, S. N. Christie, R. E. Degryse et al., Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial, Mayo Clin Proc. sept, vol.80, issue.9, p.112637, 2005.

A. Negro, M. Curto, L. Lionetto, and P. Martelletti, A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience, J Headache Pain. déc, vol.17, issue.1, p.1, 2015.

M. J. Lee, C. Lee, H. Choi, and C. Chung, Factors associated with favorable outcome in botulinum toxin A treatment for chronic migraine: A clinic-based prospective study, J Neurol Sci. 15 avr, vol.363, p.514, 2016.

E. Cernuda-morollón, P. Martínez-camblor, C. Ramón, D. Larrosa, E. Serrano-pertierra et al., CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine, Headache. juin, vol.54, issue.6, p.98795, 2014.

E. Cernuda-morollón, C. Ramón, P. Martínez-camblor, E. Serrano-pertierra, D. Larrosa et al., OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine, Pain. mai, vol.156, issue.5, p.8204, 2015.

R. K. Cady, C. P. Schreiber, J. Porter, A. M. Blumenfeld, and K. U. Farmer, A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine, Headache J Head Face Pain. 1 janv, vol.51, issue.1, p.2132, 2011.

A. M. Blumenfeld, J. D. Schim, and T. J. Chippendale, Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine, Headache. févr, vol.48, issue.2, p.21020, 2008.

. Al-rodhan, . Nrf, J. L. Fox, A. Al-zahrawi, and . Neurosurgery, Surg Neurol. 1 juill, vol.26, issue.1, p.925, 1986.

J. E. Janis, D. A. Hatef, E. M. Reece, P. D. Mccluskey, T. A. Schaub et al., Neurovascular compression of the greater occipital nerve: implications for migraine headaches, Plast Reconstr Surg. déc, vol.126, issue.6, 2010.

K. J. Chepla, E. Oh, and B. Guyuron, Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache, Plast Reconstr Surg. avr, vol.129, issue.4, pp.656-62, 2012.

M. Fallucco, J. E. Janis, and R. R. Hagan, The anatomical morphology of the supraorbital notch: clinical relevance to the surgical treatment of migraine headaches, Plast Reconstr Surg. déc, vol.130, issue.6, p.122733, 2012.

S. D. Silberstein and J. Rosenberg, Multispecialty consensus on diagnosis and treatment of headache, Neurology. 25 avr, vol.54, issue.8, p.1553, 2000.

I. Ducic, E. C. Hartmann, and E. E. Larson, Indications and outcomes for surgical treatment of patients with chronic migraine headaches caused by occipital neuralgia, Plast Reconstr Surg. mai, vol.123, issue.5, p.145361, 2009.

K. Meissner, M. Fässler, G. Rücker, J. Kleijnen, A. Hróbjartsson et al., Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis, JAMA Intern Med, vol.173, issue.21, p.194151, 2013.

P. G. Mathew, A critical evaluation of migraine trigger site deactivation surgery, Headache. janv, vol.54, issue.1, p.14252, 2014.

E. Loder, E. Weizenbaum, B. Frishberg, and S. Silberstein, American Headache Society Choosing Wisely Task Force. Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question, Headache. déc, vol.53, issue.10, p.16519, 2013.